---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-007528"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:53:15.814437+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences prices $4.5M underwritten offering of 735,000 shares at $6.12/share

## Summary
- Offering of 735,000 common shares at $6.12 each for gross proceeds of ~$4.5M; net proceeds ~$3.9M after discounts and expenses.
- Expected to close on or about October 14, 2025, subject to customary closing conditions.
- Net proceeds to be used for working capital, general corporate purposes, and advancement of DNase technology.
- Canaccord Genuity is sole bookrunner; offering made under effective shelf registration statement (File No. 333-282756).

## SEC filing metadata
- accession: 0001683168-25-007528
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316825007528/0001683168-25-007528-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316825007528/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-007528
- JSON: https://secwatch.observer/filing/0001683168-25-007528.json
- Plain text: https://secwatch.observer/filing/0001683168-25-007528.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.